Involvement of mitogen-activated protein kinases and p21Waf1 in hydroxyurea-induced G1 arrest and senescence of McA-RH7777 rat hepatoma cell line

Experimental and Molecular Medicine

Volumn 36, Issue 5, 2004, Pages 493-498

  Hong, Seung Hee ^a   Hong, Bum Sik ^b   Kim, Dae Cheol ^b   Rho, Mee Sook ^b   Park, Joo In ^b   Rha, Soe Hee ^b   Jun, Ho Sun ^c   Jeong, Jin Sook ^b  

^a National Cancer Center   (South Korea)

^b Dong A University College of Medicine   (South Korea)

^c Masan College   (South Korea)

Author keywords

Hydroxyurea; MAP kinases; p21Waf1; Rat hepatoma cells

Indexed keywords

BETA GALACTOSIDASE; HYDROXYUREA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN P21;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL GROWTH; CELL LINE; DNA CONTENT; ENZYME PHOSPHORYLATION; GROWTH INHIBITION; HEMATOLOGIC DISEASE; HEPATOMA CELL; NECROSIS; NONHUMAN; PROTEIN FAMILY; RAT; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 9344242927     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.1038/emm.2004.62     Document Type: Article

References (24)

1. Alter BP, Gilbert HS. The effect of hydroxyurea on hemoglobin F in patients with myeloproliferative syndromes. Blood 1985;66:373-9
2. Barranco SC, Haenelt BR, Gee EL. Differential sensitivities of five rat hepatoma cell lines to anticancer drugs. Cancer Res 1978;38:656-60
3. Cameron IL, Rogers W. Total intravenous hyperalimentation, hydroxyurea chemotheraphy in hepatoma-bearing rats. J Surg Res 1977;23:297-88
4. Charache S, Terrin ML, Moore RD, Dover GJ, Barton FB, Eckert SV, McMahon RP, Bonds DR. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. N Engl J Med 1995;332:1317-22
5. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira-Smith O. A biomarker that identifies senescent human cells in culture, in aging skin in vivo. Proc Natl Acad Sci USA 1995;92: 9363-7
6. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parson R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B. Wafl, a potential mediator of p53 tumor suppression. Cell 1993;75:817-25
7. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993;75:805-16
8. Ichijo H. From receptors to stress-activated MAP kinases. Oncogene 1999;18:6087-93
9. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW. Participation of p53 protein in the cellular response to DNA damage. Cancer Res 1991;51:6304-11
10. Kim YR, Cha HY, Lim K, Hwang BD, Hoe KL, Namgung UK, Park SK. Activation of epidermal growth factor receptor is responsible for pervanadate-induced phospholipase D activation. Exp Mol Med 2003;35:118-24
11. Krakoff IH, Brown NC, Reichard P. Inhibition of ribonucleotide diphosphate reductase by hydroxyurea. Cancer Res 1968;28:1559-65
12. Lewis TS, Shapiro PS, Ahn NG. Signal transduction through MAP kinase cascades. Adv Cancer Res 1998;74:49-139
13. Mata F, Rius C, Cabanas C, Bernabeu C, Aller P. S-phase inhibitors induce vimentin expression in human promonocytic U-937 cells. FEBS Lett 1989;259:171-4
14. Minden A, Karin M. Regulation, function of the JNK subgroup of MAP kinases. Biochim Biophys Acta 1997;1333:F85-104
15. Park JI, Jeong JS, Han JY, Kim DI, Gao YH, Park SC, Rodgers GP, Kim IH. Hydroxyurea induces a senescence-like change of K562 human erythroleukemia cell. Cancer Res Clin Oncol 2000;126:455-60
16. Plagemann PGW, Erbe J. Intracellular conversion of deoxyribonucleosides by Novikoff rat hepatoma cells, effects of hydroxyurea. J Cell Physiol 1974;83:321-36
17. Seger R, Krebs EG. The MAPK signaling cascade. FASEB J 1995;9:726-35
18. Seo HR, Kwan YW, Cho CK, Bae SW, Lee SJ, Soh JW, Chung HY, Lee YS. PKCα induces differentiation through ERK1/2 phosphorylation in mouse keratinocytes. Exp Mol Med 2004;36:292-9
19. Stanulis-Praeger BM. Cellular senescence revisited: a review. Mech Ageing Dev 1987;38:1-48
20. CIP1 in spontaneously immortalized human fibroblasts. Cell Growth Differ 1998;9:139-46
21. Walder S, Haynes H, Schechner R, Rozenblit A, Wiernik PH. Phase I trial of high-dose infusional hydroxyurea, high-dose infusional 5-fluorouracil, recombinant interferon-alpha-2α in patients with advanced malignancy. Invest New Drugs 1996; 13:315-20
22. waf expression in H1299 cell line promotes cell senescence, protects against cytotoxic effect of radiation, doxorubicin. Oncogene 1999;18: 2643-9
23. Xiao H, Hasegawa R, Miyaishi O, Ohkusu K, Isobe K. Sodium butyrate induces NIH3T3 cells to senescence-like state, enhances promoter activity of p21WAF/CIP1 in a p53-independent manner. Biochem Biophys Res Commmun 1997;237:457-60
24. Zhou G, Bao ZQ, Dixon JE. Components of a new human protein kinase signal transduction pathway. J Biol Chem 1995;270:12665-9